ID   MDC1_RAT                Reviewed;        1279 AA.
AC   Q5U2M8; Q6MG15;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 2.
DT   24-JUL-2024, entry version 143.
DE   RecName: Full=Mediator of DNA damage checkpoint protein 1;
GN   Name=Mdc1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15060004; DOI=10.1101/gr.1987704;
RA   Hurt P., Walter L., Sudbrak R., Klages S., Mueller I., Shiina T., Inoko H.,
RA   Lehrach H., Guenther E., Reinhardt R., Himmelbauer H.;
RT   "The genomic sequence and comparative analysis of the rat major
RT   histocompatibility complex.";
RL   Genome Res. 14:631-639(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Brown Norway; TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-168; SER-176; SER-298;
RP   SER-350; SER-354; THR-356; SER-380; THR-382; SER-411; SER-421; SER-438;
RP   THR-440; SER-550; SER-587; SER-589; SER-793 AND SER-801, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Histone reader protein required for checkpoint-mediated cell
CC       cycle arrest in response to DNA damage within both the S phase and G2/M
CC       phases of the cell cycle. Specifically recognizes and binds histone
CC       H2AX phosphorylated at 'Ser-139', a marker of DNA damage, serving as a
CC       scaffold for the recruitment of DNA repair and signal transduction
CC       proteins to discrete foci of DNA damage sites. Also required for
CC       downstream events subsequent to the recruitment of these proteins.
CC       These include phosphorylation and activation of the ATM, CHEK1 and
CC       CHEK2 kinases, and stabilization of TP53/p53 and apoptosis. ATM and
CC       CHEK2 may also be activated independently by a parallel pathway
CC       mediated by TP53BP1. Required for chromosomal stability during mitosis
CC       by promoting recruitment of TOPBP1 to DNA double strand breaks (DSBs):
CC       TOPBP1 forms filamentous assemblies that bridge MDC1 and tether broken
CC       chromosomes during mitosis. Required for the repair of DSBs via
CC       homologous recombination by promoting recruitment of NBN component of
CC       the MRN complex to DSBs. {ECO:0000250|UniProtKB:Q14676}.
CC   -!- SUBUNIT: Homodimer. Interacts with H2AX, which requires phosphorylation
CC       of H2AX on 'Ser-139'. Interacts with the MRN complex, composed of
CC       MRE11, RAD50, and NBN. Interacts with CHEK2, which requires ATM-
CC       mediated phosphorylation of 'Thr-68' within the FHA domain of CHEK2.
CC       Interacts constitutively with the BRCA1-BARD1 complex, SMC1A and
CC       TP53BP1. Interacts with ATM and FANCD2, and these interactions are
CC       reduced upon DNA damage. Also interacts with the PRKDC complex,
CC       composed of XRCC6/KU70, XRCC5/KU80 and PRKDC/XRCC7. This interaction
CC       may be required for PRKDC autophosphorylation, which is essential for
CC       DNA double strand break (DSB) repair. When phosphorylated by ATM,
CC       interacts with RNF8 (via FHA domain). Interacts with CEP164. When
CC       phosphorylated, interacts with APTX (via FHA-like domain). Interacts
CC       (when phosphorylated) with TOPBP1; promoting TOPBP1 localization to DNA
CC       damage sites during mitosis. Interacts (when phosphorylated) with NBN;
CC       promoting NBN and MRN complex localization to DNA damage sites (By
CC       similarity). {ECO:0000250|UniProtKB:Q14676}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q14676}.
CC       Chromosome {ECO:0000250|UniProtKB:Q14676}. Note=Associated with
CC       chromatin. Relocalizes to discrete nuclear foci following DNA damage,
CC       this requires 'Ser-139' phosphorylation of H2AX. Colocalizes with APTX
CC       at sites of DNA double-strand breaks. {ECO:0000250|UniProtKB:Q14676}.
CC   -!- DOMAIN: Tandemly repeated BRCT domains are characteristic of proteins
CC       involved in DNA damage signaling. In MDC1, these repeats are required
CC       for localization to chromatin which flanks sites of DNA damage marked
CC       by 'Ser-139' phosphorylation of H2AX. {ECO:0000250|UniProtKB:Q14676}.
CC   -!- PTM: Phosphorylated upon exposure to ionizing radiation (IR),
CC       ultraviolet radiation (UV), and hydroxyurea (HU). Phosphorylation in
CC       response to IR requires ATM, NBN, and possibly CHEK2. Also
CC       phosphorylated during the G2/M phase of the cell cycle and during
CC       activation of the mitotic spindle checkpoint. Phosphorylation at Thr-4
CC       by ATM stabilizes and enhances homodimerization via the FHA domain.
CC       Phosphorylated at Ser-168 and Ser-198 by CK2 in response to DNA damage
CC       during mitosis, promoting interaction with TOPBP1. Phosphorylated by
CC       CK2 in response to DNA damage, promoting interaction with NBN and
CC       recruitment of the MRN complex to DNA damage sites.
CC       {ECO:0000250|UniProtKB:Q14676}.
CC   -!- PTM: Sumoylation at Lys-1034 by PIAS4 following DNA damage promotes
CC       ubiquitin-mediated degradation. {ECO:0000250|UniProtKB:Q14676}.
CC   -!- PTM: Ubiquitinated by RNF4, leading to proteasomal degradation;
CC       undergoes 'Lys-48'-linked polyubiquitination.
CC       {ECO:0000250|UniProtKB:Q14676}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH85955.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAE84032.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX883048; CAE84032.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC085955; AAH85955.1; ALT_INIT; mRNA.
DR   RefSeq; NP_001159747.1; NM_001166275.1.
DR   AlphaFoldDB; Q5U2M8; -.
DR   SMR; Q5U2M8; -.
DR   STRING; 10116.ENSRNOP00000049009; -.
DR   iPTMnet; Q5U2M8; -.
DR   PhosphoSitePlus; Q5U2M8; -.
DR   PaxDb; 10116-ENSRNOP00000049009; -.
DR   Ensembl; ENSRNOT00000046798.5; ENSRNOP00000049009.4; ENSRNOG00000032813.5.
DR   Ensembl; ENSRNOT00055011175; ENSRNOP00055008749; ENSRNOG00055006814.
DR   Ensembl; ENSRNOT00060006170; ENSRNOP00060004579; ENSRNOG00060003725.
DR   GeneID; 309595; -.
DR   KEGG; rno:309595; -.
DR   UCSC; RGD:1559468; rat.
DR   AGR; RGD:1559468; -.
DR   CTD; 9656; -.
DR   RGD; 1559468; Mdc1.
DR   eggNOG; KOG2043; Eukaryota.
DR   GeneTree; ENSGT00940000161757; -.
DR   HOGENOM; CLU_003038_0_0_1; -.
DR   InParanoid; Q5U2M8; -.
DR   OrthoDB; 19990at2759; -.
DR   PhylomeDB; Q5U2M8; -.
DR   Reactome; R-RNO-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-RNO-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-RNO-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-RNO-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-RNO-69473; G2/M DNA damage checkpoint.
DR   PRO; PR:Q5U2M8; -.
DR   Proteomes; UP000002494; Chromosome 20.
DR   Bgee; ENSRNOG00000032813; Expressed in testis and 18 other cell types or tissues.
DR   GO; GO:0005694; C:chromosome; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0035861; C:site of double-strand break; ISS:UniProtKB.
DR   GO; GO:0140463; F:chromatin-protein adaptor activity; ISS:UniProtKB.
DR   GO; GO:0140566; F:histone reader activity; ISS:UniProtKB.
DR   GO; GO:0006974; P:DNA damage response; ISO:RGD.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0000076; P:DNA replication checkpoint signaling; ISS:UniProtKB.
DR   GO; GO:1990166; P:protein localization to site of double-strand break; ISS:UniProtKB.
DR   CDD; cd17744; BRCT_MDC1_rpt1; 1.
DR   CDD; cd18441; BRCT_MDC1_rpt2; 1.
DR   CDD; cd22665; FHA_MDC1; 1.
DR   Gene3D; 2.60.200.20; -; 1.
DR   Gene3D; 3.40.50.10190; BRCT domain; 2.
DR   InterPro; IPR001357; BRCT_dom.
DR   InterPro; IPR036420; BRCT_dom_sf.
DR   InterPro; IPR051579; DDR_Transcriptional_Reg.
DR   InterPro; IPR000253; FHA_dom.
DR   InterPro; IPR008984; SMAD_FHA_dom_sf.
DR   PANTHER; PTHR23196:SF1; MEDIATOR OF DNA DAMAGE CHECKPOINT PROTEIN 1; 1.
DR   PANTHER; PTHR23196; PAX TRANSCRIPTION ACTIVATION DOMAIN INTERACTING PROTEIN; 1.
DR   Pfam; PF16589; BRCT_2; 1.
DR   Pfam; PF00498; FHA; 1.
DR   Pfam; PF16770; RTT107_BRCT_5; 1.
DR   SMART; SM00292; BRCT; 2.
DR   SMART; SM00240; FHA; 1.
DR   SUPFAM; SSF52113; BRCT domain; 2.
DR   SUPFAM; SSF49879; SMAD/FHA domain; 1.
DR   PROSITE; PS50172; BRCT; 2.
DR   PROSITE; PS50006; FHA_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cell cycle; Chromosome; DNA damage; DNA repair;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Ubl conjugation.
FT   CHAIN           1..1279
FT                   /note="Mediator of DNA damage checkpoint protein 1"
FT                   /id="PRO_0000096321"
FT   DOMAIN          54..105
FT                   /note="FHA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00086"
FT   DOMAIN          1085..1163
FT                   /note="BRCT 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   DOMAIN          1184..1275
FT                   /note="BRCT 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   REGION          1..150
FT                   /note="Interaction with CHEK2"
FT                   /evidence="ECO:0000250"
FT   REGION          1..22
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2..222
FT                   /note="Interaction with the MRN complex"
FT                   /evidence="ECO:0000250"
FT   REGION          156..394
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          409..634
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          714..744
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          772..1086
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..19
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        179..198
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        218..236
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        304..326
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        353..367
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        434..458
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        477..491
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        601..615
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        617..634
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        797..831
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        842..932
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        941..968
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        985..1015
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1016..1044
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1051..1066
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         4
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14676"
FT   MOD_RES         146
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14676"
FT   MOD_RES         168
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         176
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         198
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14676"
FT   MOD_RES         220
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14676"
FT   MOD_RES         222
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14676"
FT   MOD_RES         298
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         300
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14676"
FT   MOD_RES         314
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14676"
FT   MOD_RES         316
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14676"
FT   MOD_RES         350
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         354
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         356
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         372
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14676"
FT   MOD_RES         380
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         382
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         394
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14676"
FT   MOD_RES         411
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         421
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         434
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5PSV9"
FT   MOD_RES         438
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         440
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         457
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5PSV9"
FT   MOD_RES         466
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5PSV9"
FT   MOD_RES         488
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5PSV9"
FT   MOD_RES         489
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5PSV9"
FT   MOD_RES         550
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         587
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         589
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         730
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14676"
FT   MOD_RES         745
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14676"
FT   MOD_RES         764
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14676"
FT   MOD_RES         793
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         801
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         824
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14676"
FT   MOD_RES         889
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14676"
FT   MOD_RES         951
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14676"
FT   MOD_RES         1008
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5PSV9"
FT   MOD_RES         1009
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5PSV9"
FT   MOD_RES         1012
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5PSV9"
FT   MOD_RES         1016
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5PSV9"
FT   MOD_RES         1054
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5PSV9"
FT   CROSSLNK        991
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14676"
FT   CROSSLNK        1034
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q14676"
FT   CROSSLNK        1034
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q14676"
SQ   SEQUENCE   1279 AA;  136948 MW;  C89F981C5B08DCAA CRC64;
     MENTQVIDWD AEEEEETEIS SGSLGYSVEP IGRLRFFSGT HGPERDFPLY LGKNVVGRSP
     DCSVALPFPS ISKQHAVIEI SAWNKAPILQ DCGSLNGTQI VKPPRVLAPG VSHRLRDQEL
     ILFADFPCQY HRLNVPPPLV PRSLLTIEKT PRIRGRSQNS RVLLAEDSEE EGDFPSGRSV
     ANGSRNTASP SATVVPESDE EGSSPGPSVP GPSSPFGLGS DTDESQGQQP GVEESSLADN
     SGAAGEPEQP EVNGVTTGTL AQPTKDKFKD TKMKEEAGSA GVPVGSVVEG SPTLGEDSDT
     EADEERQPSG SGDSDTDVEE ERVPVKKNQV LLGVGIGGPG ARGVAHLQDS PTGSDTDVEE
     DKTALAAPPE RSHTAMVINS DTDEEERGEE EEVSAALTLA RLKERGIALW SGEPGTEEVK
     SQPQVLVERS QSASGRDSDT DVEEGSSGGK REIVPDSPMD VDETLTVTQP ESQPPCRPND
     VDEDVDMSSP GSHLEGKKAS SALVDKNRAQ VEEEVPGPSV TLGEKHQVPL EGAQPPEEAR
     ETAVQEGSSS PVADIRMSQQ PVAEDAGTEC AAAVSEQKSA LEVGAQSRSP AAPVEQVVVR
     TDTSGDPTLP QREGAQTPTG REREAHVGGT KHAKECCDEP EDLCLSATQC FVEGESQHPG
     AVQSLEDEPT QVFPCLPQEP GPSHLSLPTP GADTLDVPWE VLATQPFCLR EQTETSEPID
     THEAHGSQPS LPGEPPGHQH PVPTSLDHTE LLRIDDREMQ TVEKAMGHLS CQMMPDGKAS
     GDDPEPSDHR LFSPVPEASA SPQSLLTSQS QKQSTPQPMF PTSSSELALP ETLHTKPNVR
     PRRSSRMTPS PHSSAALKPY TTCPTNQPAA SRPTSRPTRG RANRSSTRTP ELIVPTGPEL
     QPSTSTEQPG IPNLTSQVTE GRAHSTSVNM PEPVLTGPEA QPLTSAEQSV TSNLNPRAQP
     LTLEPVPQTS HQRRRRATGK QGSRTAPVGP KSYSTPAEPE PQSSASQSSG ASEADSPHQK
     RPRRQVTQKT VVVKEEDPGE IQVKEEPQET AIPTPGKRKR DPAEGETQGN PTRSRRTKPN
     QEAAAPKVLF TGVVDSRGER AVLALGGSLA SSVNEASHLV TDRIRRTVKF LCAVGKGIPI
     LSLNWLYQSR KAGCFLPPDD YLVTDPEQEK NFSFSLRDSL SRARERRLLE DYEIHVTPGV
     QPPPPQMGEI ISCCGGTVLP SMPHSYKLHR VVITCTEDLP RCAIASRLGL PLLSPEFLLT
     GVLKQEATPE AFVLSNLEM
//
